Business Description
Rubicon Research Ltd
ISIN : INE506V01022
Total Employee Number:
1,885Compare
Compare
Traded in other countries / regions
RUBICON.India IPO Date
2025-10-16Description
Rubicon Research Ltd is a pharmaceutical formulations company specializing in developing, manufacturing, and marketing branded specialty and generic prescription products. Starting as a provider of contract formulation development services, the company expanded to operate an oral solids manufacturing facility in India, offering contract development and manufacturing services for regulated markets. The company's diverse product portfolio covers multiple therapeutic areas, including analgesics and pain management, CVS, CNS, hypokalemia, skeletal muscle relaxants, NRT, gastrointestinal, metabolic, and immunosuppressants. The company operates in India, the USA, and other markets, with the majority of its revenue coming from the USA.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.08 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 0.85 | |||||
Interest Coverage | 10.77 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 19.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 66.3 | |||||
3-Year EBITDA Growth Rate | 113.6 | |||||
3-Year FCF Growth Rate | 40.9 | |||||
3-Year Book Growth Rate | 65 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 39.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 29.99 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 84.39 | |||||
9-Day RSI | 79.33 | |||||
14-Day RSI | 75.44 | |||||
3-1 Month Momentum % | 46.23 | |||||
6-1 Month Momentum % | 81.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.01 | |||||
Quick Ratio | 1.14 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 448.01 | |||||
Days Sales Outstanding | 91.45 | |||||
Days Payable | 202.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.08 | |||||
Forward Dividend Yield % | 0.08 | |||||
5-Year Yield-on-Cost % | 0.08 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.71 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.48 | |||||
Operating Margin % | 20.8 | |||||
Net Margin % | 15.38 | |||||
EBITDA Margin % | 24.15 | |||||
FCF Margin % | -6.52 | |||||
OCF Margin % | 2.88 | |||||
ROE % | 29.01 | |||||
ROA % | 12.96 | |||||
ROIC % | 19.45 | |||||
3-Year ROIIC % | 29.67 | |||||
ROC (Joel Greenblatt) % | 33.8 | |||||
ROCE % | 32.75 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 127.67 | |||||
Forward PE Ratio | 83.91 | |||||
PE Ratio without NRI | 127.67 | |||||
PS Ratio | 19.64 | |||||
PB Ratio | 23.04 | |||||
Price-to-Tangible-Book | 24.26 | |||||
Price-to-Operating-Cash-Flow | 674.47 | |||||
EV-to-EBIT | 90.17 | |||||
EV-to-EBITDA | 80.62 | |||||
EV-to-Revenue | 19.47 | |||||
EV-to-FCF | -298.43 | |||||
Price-to-Graham-Number | 11.84 | |||||
| Price-to-Net-Current-Asset-Value | 46.12 | |||||
Earnings Yield (Greenblatt) % | 1.11 | |||||
FCF Yield % | -0.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rubicon Research Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 15,237.82 | ||
| EPS (TTM) (₹) | 14.09 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 75.44 | ||
| 14-Day ATR (₹) | 73.500129 | ||
| 20-Day SMA (₹) | 1594.04 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 570.75 - 1820.1 | ||
| Shares Outstanding (Mil) | 165.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rubicon Research Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rubicon Research Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 1.500000 Cash Dividend | 2026-08-07 | 1,533.40 (-2.58%) |
Show
Entries
Rubicon Research Ltd Frequently Asked Questions
What is Rubicon Research Ltd(NSE:RUBICON)'s stock price today?
The current price of NSE:RUBICON is ₹1798.80. The 52 week high of NSE:RUBICON is ₹1820.10 and 52 week low is ₹570.75.
When is next earnings date of Rubicon Research Ltd(NSE:RUBICON)?
The next earnings date of Rubicon Research Ltd(NSE:RUBICON) is .
Does Rubicon Research Ltd(NSE:RUBICON) pay dividends? If so, how much?
The Dividend Yield %  of Rubicon Research Ltd(NSE:RUBICON) is 0.08% (As of Today), Highest Dividend Payout Ratio of Rubicon Research Ltd(NSE:RUBICON) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Rubicon Research Ltd(NSE:RUBICON) is 0.08%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Rubicon Research Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers